RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,960,000 | -9.7% | 4,000,000 | -20.0% | 2.89% | -1.8% |
| Q4 2021 | $13,250,000 | +84.4% | 5,000,000 | +152.5% | 2.94% | +76.0% |
| Q3 2021 | $7,187,000 | +10.4% | 1,980,000 | +32.0% | 1.67% | +22.5% |
| Q2 2021 | $6,510,000 | -32.5% | 1,500,000 | -56.0% | 1.37% | +2.2% |
| Q2 2018 | $9,644,000 | -100.0% | 3,407,840 | -60.3% | 1.34% | -70.4% |
| Q1 2018 | $30,371,000,000 | +99125.7% | 8,579,454 | +8.8% | 4.51% | -13.7% |
| Q4 2017 | $30,608,000 | +32.3% | 7,888,581 | -13.4% | 5.22% | +16.1% |
| Q3 2017 | $23,128,000 | -7.0% | 9,105,691 | 0.0% | 4.50% | +1.0% |
| Q2 2017 | $24,859,000 | -17.5% | 9,105,691 | 0.0% | 4.45% | -25.6% |
| Q1 2017 | $30,140,000 | +26810.7% | 9,105,691 | +18111.4% | 5.99% | +18606.2% |
| Q2 2016 | $112,000 | -65.9% | 50,000 | -68.3% | 0.03% | -72.9% |
| Q1 2016 | $328,000 | – | 157,872 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |